Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of treating cancer by administering immune effector cells expressing a chimeric antigen receptor comprising a CD20 binding domain

Method of treating cancer by administering immune effector cells expressing a chimeric antigen receptor comprising a CD20 binding domain

US Patent 11872249 · Granted Jan 16, 2024

Estimated economic value: $73,253,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Mobile phone2025
Signal communication based on levitated particle2025
To-be-executed instruction prediction method and system2025
Implementing a policy-based agent with plugin infrastructure2025
Physical uplink control channel transmission method and apparatus, device and me2025
Downlink data receiving method, downlink data sending method, and device2025
Resource configuration method, information transmission method, and related devi2025
Apparatus and method of substrate edge cleaning and substrate carrier head gap c2025
Chimeric antigen receptors and uses thereof2025
Chimeric antigen receptors and uses thereof2025
Chimeric antigen receptors and uses thereof2025
Chimeric antigen receptors and uses thereof2025